Join Now

Author Archives: admin

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in […]

Posted in BioUtah News | Comments Off on Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

Myriad Genetics Issues 2022 Environmental, Social and Governance Report

SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today released its second annual Environmental, Social and Governance report, highlighting key efforts that reflect its commitment to conduct operations as a responsible, equitable and sustainable partner in the healthcare industry. “At Myriad, […]

Posted in BioUtah News | Comments Off on Myriad Genetics Issues 2022 Environmental, Social and Governance Report

Academia in Action: Searching for rare disease treatments

By their very nature, rare diseases impact a smaller portion of the population compared to conditions like cancer or the flu. While these diseases are less common, those affected by them, along with University of Utah researchers, are actively searching for a cure. Treating patients as individuals: Clement Chow Read more about Clement Chow’s research […]

Posted in BioUtah News | Comments Off on Academia in Action: Searching for rare disease treatments

CLENE REPORTS SIGNIFICANTLY IMPROVED SURVIVAL BENEFIT OF 19.3 MONTHS AND SIGNIFICANTLY DELAYED CLINICAL WORSENING IN RESCUE-ALS OPEN-LABEL EXTENSION TWO YEAR FOLLOW-UP

19.3 month significant survival difference for CNM-Au8® treated participants versus placebo 52% significant decreased risk of ALS clinical worsening events Over 475 years of CNM-Au8 treatment exposure without any identified safety signals SALT LAKE CITY, Aug. 29, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) through its wholly owned subsidiary Clene Nanomedicine Inc., today announced […]

Posted in BioUtah News | Comments Off on CLENE REPORTS SIGNIFICANTLY IMPROVED SURVIVAL BENEFIT OF 19.3 MONTHS AND SIGNIFICANTLY DELAYED CLINICAL WORSENING IN RESCUE-ALS OPEN-LABEL EXTENSION TWO YEAR FOLLOW-UP

Final Demolition Efforts Underway at The Point

Crews to topple final guard tower and showcase sustainable demolition practices   WHAT: Members of the media are invited to get a close-up look at demolition efforts currently underway at The Point. Attendees will get exclusive views of the preserved prison chapel called the “Chapel by the Wayside” and the state-of-the-art crushing facility used to […]

Posted in BioUtah News | Comments Off on Final Demolition Efforts Underway at The Point

Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk

New collaboration increases access to genetic testing and can help identify patients with a high-risk for breast cancer SALT LAKE CITY, Aug. 22, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Onsite Women’s Health, a leading national provider of breast health services, today announced the […]

Posted in BioUtah News | Comments Off on Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk

Government Price Setting Would Lead to Lost Therapies, Innovation and Jobs in Utah

New Study Details Proposed Federal Government-Mandated Drug Pricing Policies Senate SMART Prices Act Will Cost More Than 235 Fewer FDA Approvals Up To 23,000 Lost Jobs in Utah in Coming Decade SALT LAKE CITY, July 27, 2023 – Proposed expansions of federal government-mandated drug pricing policies present serious consequences for the development of and investment in […]

Posted in BioUtah News | Comments Off on Government Price Setting Would Lead to Lost Therapies, Innovation and Jobs in Utah

Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

Valence Labs is Recursion’s new machine learning research center that aims to promote open science and academic research. $1 million will be committed to advancing the next generation of academic machine learning research through scholarships and fellowships.SALT LAKE CITY, July 26, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding […]

Posted in BioUtah News | Comments Off on Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

DEVICE FOR TREATING CHALLENGING BONE FRACTURES CLEARED BY FDA

A new system for fixing bone fractures, called the Bone Bolt System, has been approved for market by the U.S. Food and Drug Administration (FDA), the University of Utah Orthopaedic Innovation Center (OIC), Department of Orthopaedics and Spencer Fox Eccles School of Medicine announced on July 20, 2023. “This achievement demonstrates the commitment by the […]

Posted in BioUtah News | Comments Off on DEVICE FOR TREATING CHALLENGING BONE FRACTURES CLEARED BY FDA

Owlet Appoints Executive Jonathan Harris as New Company President and Chief Revenue Officer

LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), a pioneer of smart baby monitoring, today announces the appointment of executive Jonathan Harris as its new President and Chief Revenue Officer. Harris joins Owlet at a pivotal time in its business – one month after receiving clearance from the U.S. Food and Drug […]

Posted in BioUtah News | Comments Off on Owlet Appoints Executive Jonathan Harris as New Company President and Chief Revenue Officer

Bloom Surgical Awarded Competitive Grant from the NSF

Funding accelerates development of device for resolving visual disruptions in robotic procedures Salt Lake City, UT, June 1, 2023 – Bloom Surgical, Inc., a Utah-based surgical device startup, has been awarded a U.S. National Science Foundation Small Business Innovation Research grant for $256,000 to conduct research and development work on a novel micro-mechanical wiping mechanism […]

Posted in Policy News | Comments Off on Bloom Surgical Awarded Competitive Grant from the NSF

Rep. Moore Calls For Increased Transparency in the NCD Process

Utah U.S. Rep. Blake Moore (R-UT) signed onto a letter to HHS/CMS, led by House Ways and Means Committee Chair Jason Smith (R-MO) and House Energy and Commerce Committee Chair Kathy McMorris-Rodgers (R-WA), calling for increaed transparency in the NCD process following the agency’s recent release of the TCET notice. In part, the letter states, […]

Posted in Policy News | Comments Off on Rep. Moore Calls For Increased Transparency in the NCD Process